Article
KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity.
Virchows Archiv : an international journal of pathology - 1 Oct 2015
Queirós Pedro, Pinheiro Hugo, Carvalho Joana, Oliveira Patrícia, Gullo Irene, Carneiro Fátima, Almeida Gabriela M, Oliveira Carla
Abstract excerpt
In gastric cancer (GC), epidermal growth factor receptor (EGFR) overexpression associates with poor prognosis. Addition of a chimeric monoclonal antibody against EGFR (cetuximab) to first-line treatment of metastatic colorectal tumours improved outcomes of patients (stratified for KRAS wild-type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
